Showing results (331-340 of 521) with videos related to

Sort By:
Pageof 53
JACC. Heart Failure|June 23, 2014
Biomarkers of myocardial stress and fibrosis as predictors of mode of death in patients with chronic heart failureTariq Ahmad, Mona Fiuzat, Benjamin Neely, et al.
Journal of the American Heart Association|May 6, 2021
Differences in NT-proBNP Response and Prognosis in Men and Women With Heart Failure With Reduced Ejection FractionMelissa A Daubert, Eric Yow, Huiman X Barnhart, et al.
Journal of the American Society of Nephrology : JASN|February 9, 2013
SPAK differentially mediates vasopressin effects on sodium cotransportersTurgay Saritas, Aljona Borschewski, James A McCormick, et al.
Circulation. Heart Failure|June 3, 2015
Evaluation of the Incremental Prognostic Utility of Increasingly Complex Testing in Chronic Heart FailureTariq Ahmad, Emily C O'Brien, Phillip J Schulte, et al.
Journal of the American College of Cardiology|October 11, 2014
Effect of serelaxin on mode of death in acute heart failure: results from the RELAX-AHF studyG Michael Felker, John R Teerlink, Javed Butler, et al.
ESC Heart Failure|June 1, 2021
Growth differentiation factor-15, treatment with liraglutide, and clinical outcomes among patients with heart failureAbhinav Sharma, Stephen Greene, Muthiah Vaduganathan, et al.
Journal of the American Heart Association|December 8, 2020
Ultrafiltration in Acute Heart Failure: Implications of Ejection Fraction and Early Response to Treatment From CARRESS-HFMarat Fudim, Jeremy Brooksbank, Anna Giczewska, et al.
Mayo Clinic Proceedings. Innovations, Quality & Outcomes|May 17, 2021
Effects of Atrial Fibrillation on Heart Failure Outcomes and NT-proBNP Levels in the GUIDE-IT TrialFouad Chouairi, Justin Pacor, P Elliott Miller, et al.
European Journal of Heart Failure|January 31, 2017
A multimarker multi-time point-based risk stratification strategy in acute heart failure: results from the RELAX-AHF trialBiniyam G Demissei, Gad Cotter, Margaret F Prescott, et al.
Pageof 53